免疫抑制
自身免疫性肝炎
代谢物
医学
免疫学
自身免疫性疾病
肝炎
自身免疫
免疫系统
病毒学
抗体
肝炎病毒
丙型肝炎病毒
自身抗体
作者
Mengyi Xu,Luo Kangkang,Zhou Zhou,Junjie Li,Shiyao Zhang,Ling‐Dong Kong,Longfeng Jiang,Yuxuan Zhang,Yu Li,Fuyu Xiao,Chuanlong Zhu,Qiang Xu,Hongwei Yi,Xudong Wu
标识
DOI:10.1038/s41467-026-74412-2
摘要
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease typically managed with broad-spectrum immunosuppressants that carry significant systemic side effects and often provide incomplete efficacy. While gut-microbiota-derived metabolites are known to influence AIH progression, the specific microbial drivers that maintain hepatic immune homeostasis remain poorly defined. Here, we show that Bacteroides acidifaciens (BA) and its metabolite 1-oleoyl-sn-glycero-3-phosphoethanolamine (O-LysoPE) are enriched in self-healing mouse models of hepatitis but markedly depleted in AIH patients. We demonstrate that O-LysoPE induces a 'hepatocyte-driven active immunosuppression' by targeting the Qa-1b (HLA-E): NKG2A immune checkpoint. Mechanistically, O-LysoPE selectively redirects the transcription factor Creb1 to the H2T23 promoter under inflammatory conditions, thereby upregulating hepatocytic Qa-1b expression. This elevation of Qa-1b engages the inhibitory receptor NKG2A on T cells, suppressing their overactivation and restoring a quiescent phenotype. Genetic disruption of H2T23 abrogates the hepatoprotective effects of O-LysoPE, confirming the central role of this metabolic-immune axis. Our findings reveal that the BA-O-LysoPE axis mobilizes the liver's intrinsic self-rescue mechanisms to restore immune quiescence. This study establishes a robust biological framework for liver-specific, targeted immunotherapy in AIH, offering a precision alternative to current systemic immunosuppression.
科研通智能强力驱动
Strongly Powered by AbleSci AI